Daily non-political popular news in brief.
Blood test may help signal tumor's remission, return in throat cancer patients
06-01-2007 · EurekAlert!A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
Read more »
Keywords: blood, test, signal, tumor, remission, return, throat, cancer, patients, patient
« Previous | Next »
Similar news on "Blood test may help signal tumor's remission, return in throat cancer patients":
- Study suggests test for p53 is needed to prescreen patients for blood cancer drugs
03-09-2007 · EurekAlert!
Researchers have determined a way to prescreen cancer patients to see if they are suitable candidates for proteasome inhibitors, a promising class of anti-cancer drugs. They propose to test for p53, a well-known tumor-suppressor protein that is broken down by cellular machinery called proteasomes.
Similar news · Read more »
- Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
- Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
12-13-2006 · EurekAlert!
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
Similar news · Read more »
- Genetic marker linked to aggressive prostate cancer
05-20-2007 · EurekAlert!
Northwestern University researchers have discovered that a recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease. These findings ultimately will aid the development of a simple blood test to predict who is susceptible to this aggressive cancer. Knowing which patients carry this genetic marker also will guide doctors in how they treat the cancer. The study showed a strong hereditary component to this aggressive cancer.
Similar news · Read more »
- Novel method enables genomic screening of blood vessels from patient tissue
08-28-2007 · EurekAlert!
Scientists have developed a new method of capturing a complete genome-wide screening of blood vessel cells in their actual disease state, advancing the potential for genetic research on the tissue responsible for delivering nourishment that can accelerate the growth of both a cancer tumor or wound healing.
Similar news · Read more »
- Other highlights in the February 7 JNCI
02-06-2007 · EurekAlert!
Also in the February 7 JNCI, an article on second cancers among hairy cell leukemia survivors, a test to identify types of colorectal cancer, a report on problems with tumor markers, and a examination of a growth factor that may interfere with blood cell production.
Similar news · Read more »
- Transparent zebrafish help researchers track breast cancer
10-22-2007 · EurekAlert!
What if doctors could peer through a patient's skin and see a cancer tumor growing? They'd be able to study how tumor cells migrate: how they look, how they interact with the blood system to find nourishment to grow and spread through the body. Scientists at the UCSD School of Medicine can't look through human skin. But a small, tropical minnow fish common to aquariums has given researchers a window for viewing live, human cancer cells in action.
Similar news · Read more »
- Mouse tests predict drug response in relapsing pancreatic cancer patients
10-11-2006 · EurekAlert!
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
- Cancer treatment targets tumor blood supply in patients
03-02-2007 · EurekAlert!
An antibody called J591 specifically targets an antigen found in high amounts on both prostate tumors and on blood vessels of all solid tumors, according to a study by researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Similar news · Read more »
- Study produces conflicting findings on the use of anti-anemia drug in cancer patients
04-16-2007 · EurekAlert!
Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.
Similar news · Read more »
